T1	Participants 112 140	T3 resectable rectal cancer:
T2	Participants 198 345	In T3 rectal cancer (RC), preoperative chemoradiotherapy [5-fluorouracil (5-FU-RT)] reduces local recurrences, but does not affect overall survival
T3	Participants 898 966	Forty-six patients were randomized in arm A and 45 patients in arm B
